Anti-apoptotic proteins induce non-random genetic alterations that result in selecting breast cancer metastatic cells

Clinical and Experimental Metastasis

Volumn 22, Issue 4, 2005, Pages 297-307

  Méndez, Olga ^a   Fernández, Yolanda ^a   Peinado, Miguel A ^a   Moreno, Victor ^b   Sierra, Angels ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Apoptosis; Bcl 2 proteins; Bcl xL; Breast cancer; Genetic instability; Metastasis

Indexed keywords

PRIMER DNA; PROTEIN BCL 2; PROTEIN BCL XL;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER GENETICS; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA FINGERPRINTING; FEMALE; GENE OVEREXPRESSION; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KRUSKAL WALLIS TEST; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENOMIC INSTABILITY; HUMANS; MICE; MICE, NUDE; MUTAGENESIS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 25444496950     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-005-8751-x     Document Type: Article

References (41)

1. M Jaattela 1999 Escaping cell death: survival proteins in cancer Exp Cell Res 248 30 43
2. GI Evan KH Vousden 2001 Proliferation, cell cycle and apoptosis in cancer Nature 411 342 8
3. I Bieche R Lidereau 1995 Genetic alterations in breast cancer Genes Chromosomes Cancer 14 227 35
4. B Zhivotovsky G Kroemer 2004 Apoptosis and genomic instability Nature 5 752 762
5. A Sierra X Castellsague T Coll 1998 Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas Int J Cancer 79 103 10
6. L promotes metastasis of breast cancer cells by induction of cytokines resistance Cell Death Differ 7 350 9
7. DJ McConkey G Greene CA Pettaway 1996 Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line Cancer Res 56 5594 9
8. Y Fernández B Gu A Martínez 2002 Inhibition of apoptosis in human breast cancer cells: Role in tumor progression to the metastatic state Int J Cancer 101 317 26
9. PJ Real A Sierra A De Juan 2002 Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells Oncogene 21 7611 8
10. Z Zhu O Sanchez-Sweatman X Huang 2001 Anoikis and metastatic potential of cloudman S91 melanoma cells Cancer Res 61 1707 1716.10
11. NB La Thangue 2005 A mismatched role for Bcl-2 Nat Cell Biol 7 101 2
12. O Méndez S Manas MA Peinado 2001 Microsatellite instability is associated with the loss of apoptosis in ductal breast carcinomas Breast Cancer Res Treat 65 171 7
13. C Pizzi L Panico L De Marchis 2002 p53 expression is decreased in primary breast carcinomas with microsatellite instability Breast Cancer Res Treat 73 257 66
14. C Adem CL Soderberg LM Cunningham 2003 Microsatellite instability in hereditary and sporadic breast cancers Int J Cancer 107 580 2
15. A Sierra X Castellsague A Escobedo 2000 Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer Int J Cancer 89 142 7
16. N Rubio L Espana Y Fernández 2001 Metastatic behavior of human breast carcinomas overexpressing the Bcl-x(L) gene: A role in dormancy and organospecificity Lab Invest 81 725 34
17. RD Zhang IJ Fidler JE Price 1991 Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis Invasion Metastasis 11 204 5
18. EA Clark TR Golub ES Lander 2000 Genomic analysis of metastasis reveals an essential role for RhoC Nature 406 532 5
19. R Arribas G Capella S Tortola 1997 Assessment of genomic damage in colorectal cancer by DNA fingerprinting: prognostic applications J Clin Oncol 15 3230 40
20. DX Yin RT Schimke 1996 Inhibition of apoptosis by overexpressing Bcl-2 enhances gene amplification by a mechanism independent of aphidicolin pretreatment Proc Natl Acad Sci USA 93 3394 8
21. L promotes susceptibility to mutagenesis Oncogene 13 1489 97
22. Y Liu L Naumovski P Hanawalt 1997 Nucleotide excision repair capacity is attenuated in human promyelocytic HL60 cells that overexpress BCL2 Cancer Res 57 1650 3
23. Y Saintigny A Dumay S Lambert 2001 A novel role for the Bcl-2 protein family: specific suppression of the RAD51 recombination pathway EMBO J 20 2596 607
24. C Wiese AJ Pierce SS Gauny 2002 Gene conversion is strongly induced in human cells by double-strand breaks and is modulated by the expression of BCL-x(L) Cancer Res 62 1279 83
25. IP Tomlinson 2001 Mutations in normal breast tissue and breast tumours Breast Cancer Res 3 299 303
26. DP Cahill KW Kinzler B Vogelstein 1999 Genetic instability and darwinian selection in tumours Trends Cell Biol 9 57 60
27. AP Simoes-Wust T Schurpf J Hall 2002 Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide Breast Cancer Res Treat 76 157 66
28. Yang H, Sadda MR, Li M et al. S-sdenosylmethionine and its metabolite induce apoptosis in HepG2 cells: Role of protein phosphatase 1 and Bcl-x(S). 2004; 40: 221-31.
29. DR Mercatante CD Bortner JA Cidlowski 2001 Modification of alternative spliceing of Bcl-x pre-mRNA in prostate and breast cancer cells Analysis of apoptosis and cell death. 11 16411 7
30. M Perucho J Welsh MA Peinado 1995 Fingerprinting of DNA and RNA by arbitrarily primed polymerase chain reaction: Applications in cancer research Methods Enzymol 254 275 90
31. BR Brinkley PT Beall LJ Wible 1980 Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro Cancer Res 40 3118 29
32. KR Loeb LA Loeb 2000 Significance of multiple mutations in cancer Carcinogenesis 21 379 85
33. CR Boland L Ricciardiello 1999 How many mutations does it take to make a tumor? Proc Natl Acad Sci U S A 96 14675 87
34. O Schmidt-Kittler T Ragg A Daskalakis 2003 From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression Proc Natl Acad Sci USA 100 7737 42
35. RO Hynes 2003 Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell 113 821 33
36. LA Loeb 2001 A mutator phenotype in cancer Cancer Res. 61 3230 9
37. C Li CJ Fox SR Master VP Bindokas 2002 Bcl-X(L) affects Ca(2+) homeostasis by altering expression of inositol 1,4,5-trisphosphate receptors Proc Natl Acad Sci USA 99 9830 5
38. DS McClintock MT Santore VY Lee 2002 Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death Mol Cell Biol 22 94 104
39. I Tomlinson W Bodmer 1999 Selection the mutation rate and cancer: ensuring that the tail does not wag the dog Nat Med 5 11 2
40. R Bernards RA Weinberg 2002 A progression puzzle Nature 418 823
41. B Zhivotovsky G Kroemer 2004 Apoptosis and genomic instability Nat Rev Mol Cell Biol 5 752 62